Hyper Corporation

Hyper Corporation Current Liabilities

The Current Liabilities of Hyper Corporation (065650.KQ) as of Nov 4, 2026 is 6.27 B KRW. In the previous year, Current Liabilities was 19.73 B KRW — a change of -68.24% (lower).

Current Liabilities

6.27 BKRW

YoY

-68.24%

Last updated:

Current Liabilities of Hyper Corporation is 2025 6.27 B KRW. Current Liabilities of Hyper Corporation was 2024 19.73 B KRW. It decreases by -68.24% lower compared to the previous year.

The Hyper Corporation Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
1.55 B KRW
Jan 1, 2019
1.03 B KRW
Jan 1, 2020
17.43 B KRW
Jan 1, 2021
4.56 B KRW
Jan 1, 2022
1.58 B KRW
Jan 1, 2023
971.02 M KRW
Jan 1, 2024
19.73 B KRW
Jan 1, 2025
6.27 B KRW
The Hyper Corporation Current Liabilities history
YEARCurrent LiabilitiesYoY
6.27 BKRW-68.24%
19.73 BKRW+1,931.71%
971.02 MKRW-38.65%
1.58 BKRW-65.28%
4.56 BKRW-73.84%
17.43 BKRW+1,599.24%
1.03 BKRW-33.77%
1.55 BKRW+97.09%
785.73 MKRW-50.97%
1.60 BKRW-74.02%
6.17 BKRW+1,467.94%
393.43 MKRW+51.91%
259.00 MKRW+18.65%
218.29 MKRW-48.40%
423.01 MKRW-85.09%
2.84 BKRW-33.08%
4.24 BKRW+11.34%
3.81 BKRW-58.49%
9.18 BKRW+2,132.60%
411.00 MKRW-56.18%
938.00 MKRW-75.47%
3.82 BKRW+102.01%
1.89 BKRW+47.89%
1.28 BKRW+29.95%
985.00 MKRW-8.20%
1.07 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Current Liabilities of Hyper Corporation is 6.27 B KRW in 2025.

Current Liabilities of Hyper Corporation changed from 19.73 B KRW to 6.27 B KRW, representing a -68.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Hyper Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Hyper Corporation

All Key Metrics — Hyper Corporation